Profil Penderita Hepatitis B Kronik Yang Mendapat Terapi Antiviral Di RSUD Ar…

Chronic hepatitis B is a global health problem. Hepatitis B virus (HBV) had infected 2 billion of the world’s population, and 257 million of them suffer chronic hepatitis B. There are two classes of antiviral therapy (interferon and nucleos(t)ida analogues) which aim to suppress viral replication and eventally prevent the progression of necroinflamation in the liver. This study aimed to deter…